Suppression of phrenic nerve activity as a potential predictor of imminent sudden unexpected death in epilepsy (SUDEP). (15th February 2021)

• Record Type: Journal Article
• Authors: Ashraf, Omar; Huynh, Trong; Purnell, Benton S.; Murugan, Madhuvika; Fedele, Denise E.; Chitravanshi, Vineet; Boison, Detlev
• Is Part Of: Neuropharmacology. Volume 184(2021)
• Publication Date: 2021-02-15
• Subjects: Sudden unexpected death in epilepsy -- Seizures -- Epilepsy -- Phrenic nerve activity -- Adenosine; Neuropsychopharmacology -- Periodicals; Autonomic Agents -- Periodicals; Neuropsychopharmacologie -- Périodiques; Neuropsychopharmacology; Periodicals; Electronic journals; 615.78
• DOI: 10.1016/j.neuropharm.2020.108405
• Languages: English
• ISSNs: 0028-3908

Abstract

Abstract: Sudden unexpected death in epilepsy (SUDEP) is a leading cause of death in patients with refractory epilepsy. Centrally-mediated respiratory dysfunction has been identified as one of the principal mechanisms responsible for SUDEP. Seizures generate a surge in adenosine release. Elevated adenosine levels suppress breathing. Insufficient metabolic clearance of a seizure-induced adenosine surge might be a precipitating factor in SUDEP. In order to deliver targeted therapies to prevent SUDEP, reliable biomarkers must be identified to enable prompt intervention. Because of the integral role of the phrenic nerve in breathing, we hypothesized that suppression of phrenic nerve activity could be utilized as predictive biomarker for imminent SUDEP. We used a rat model of kainic acid-induced seizures in combination with pharmacological suppression of metabolic adenosine clearance to trigger seizure-induced death in tracheostomized rats. Recordings of EEG, blood pressure, and phrenic nerve activity were made concomitant to the seizure. We found suppression of phrenic nerve burst frequency to 58.9% of baseline ( p < 0.001, one-way ANOVA) which preceded seizure-induced death; importantly, irregularities of phrenic nerve activity were partly reversible by the adenosine receptor antagonist caffeine. Suppression of phrenic nerve activity may be a useful biomarker for imminent SUDEP. The ability to reliably detect the onset of SUDEP may be instrumental in the timely administration of potentially lifesaving interventions. Highlights: Research Highlights: Seizures in combination with increased adenosine can suppress phrenic nerve firing. Suppression of the phrenic nerve precedes cardiovascular failure and EEG flattening. Suppression of phrenic nerve activity is a potential biomarker for imminent SUDEP. Phrenic nerve irregularities are partially restored by caffeine.